-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QFKOUWFmrJswLYSFZI+bv+Y50DbdvZXQ9Gs8CuVnMvvd1X4Ok0UIvUkDlqKQvIGq Fa2C6o1QhUktf4SCOgbdug== 0001209191-08-002302.txt : 20080107 0001209191-08-002302.hdr.sgml : 20080107 20080107131718 ACCESSION NUMBER: 0001209191-08-002302 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080103 FILED AS OF DATE: 20080107 DATE AS OF CHANGE: 20080107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMOS CORP CENTRAL INDEX KEY: 0000713275 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363207413 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 WOOD AVENUE SOUTH STREET 2: SUITE 301 CITY: ISELIN STATE: NJ ZIP: 08830 BUSINESS PHONE: 7324529556 MAIL ADDRESS: STREET 1: 99 WOOD AVENUE SOUTH STREET 2: SUITE 301 CITY: ISELIN STATE: NJ ZIP: 08830 FORMER COMPANY: FORMER CONFORMED NAME: PHARMATEC INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MILLER LLOYD I III CENTRAL INDEX KEY: 0000949119 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11550 FILM NUMBER: 08514409 BUSINESS ADDRESS: STREET 1: 4650 GORDON DRIVE CITY: NAPLES STATE: FL ZIP: 33940 BUSINESS PHONE: 9412628577 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2008-01-03 0 0000713275 PHARMOS CORP PARS 0000949119 MILLER LLOYD I III 4550 GORDON DRIVE NAPLES FL 34102 0 0 1 0 Common Stock 1603097 I By Milfam II L.P. Common Stock 352178 I By Trust A-4 - Lloyd I. Miller Common Stock 10000 D 10% Convertible Debenture 0.70 2008-01-03 4 P 0 1000000 0.00 A 2012-11-01 Common Stock 1428572 1000000 D Stock Options 1.84 2017-01-16 Common Stock 20000 20000 D The reporting person disclaims beneficial ownership of these securities to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Act or otherwise, the benefical owner of any equity securities covered by this filing. Between 11/1/08 and 10/31/09, the debenture is convertible into shares of common stock at the option of the holder to the extent that the holder would not beneficially own in excess of 4.99% of the total number of shares of the issuer's outstanding common stock immediately after giving effect to such conversion. The debenture is freely convertible without restriction at any time on or after 11/1/09. This is the maturity date of the debenture. Represents the number of shares issuable upon conversion of the principal amount of the debenture. Lloyd I. Miller, III acquired the 10% Convertible Debenture due November 1, 2012 in the principal amount of $1,000,000.00 in connection with that certain Securities Purchase Agreement dated January 3, 2008, between the Issuer and the investors thereto. 25% of the options become exercisable on 1/17/08; the remaining 75% become exercisable in twelve equal increments on a quarterly basis beginning on 4/17/08. /s/ Paul N. Silverstein Attorney-in-fact 2008-01-07 -----END PRIVACY-ENHANCED MESSAGE-----